Stocks
G1 Therapeutics (GTHX) FCF US GAAP (year values) |
|||||||||
| FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | LTM ? | CAGR 5 years ? | |||
| FCF, bln rub | ? | -102.3 | -83.7 | -132.1 | -129.1 | -38.3 | -37.5 | ||
| Changes by years, y/y, % | +36% | -18% | +58% | -2% | -70% | -12.6% | |||
G1 Therapeutics. FCF, bln rub
G1 Therapeutics. FCF, changes, %
G1 Therapeutics. FCF, sum by quarters, bln rub
G1 Therapeutics (GTHX) FCF US GAAP (quarter values) |
||||||||
| FY2023Q2 | FY2023Q3 | FY2023Q4 | FY2024Q1 | FY2024Q2 | LTM ? | |||
| FCF, bln rub | ? | 14.1 | -10.6 | -12.8 | -8.90 | -5.27 | -37.5 | |
| Changes by years, y/y, % | -136% | -50% | -58% | -69% | -137% | |||
| Changes by quarters, q/q, % | -148% | -175% | +21% | -30% | -41% | |||
